Novo Nordisk stock tumbles 15% despite strong earnings: here’s what spooked investors February 4, 2026 Novo Nordisk stock (NVO) plunged approximately 15% after the Danish pharmaceutical giant posted better-than-expected 2025 results but delivered a…
Evening digest: Walmart’s $1T mark, Novo’s weak outlook, Bitcoin slips below $74K February 4, 2026 Tonight’s digest tracks a trillion-dollar retail coronation, a fragile geopolitical tariff truce, a pharma darling losing its halo, and…
